XML 58 R42.htm IDEA: XBRL DOCUMENT v3.3.1.900
Stockholders' Equity (10K) (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2015
Dec. 31, 2014
Stockholders' Equity [Abstract]    
Stock Compensation Plans Information Summary  

Information with respect to the Stock Compensation Plans at December 31, 2014 is as follows:

 
1999 Option
Plan
2009 Stock
Compensation Plan
2011 Stock
Compensation Plan
Individual
Plans
Shares authorized for issuance
4,000
7,000
150,000
Option vesting period
Quarterly over
3 years
Quarterly over
3 years
Immediate/Quarterly
over 3 years
Quarterly over
3 years
Date adopted by stockholders
June 2009
November 2011
Option term
7 Years
7 Years
7 Years
7 Years
Options outstanding
25
425
71,437
125
Options exercisable
25
425
56,483
125
Weighted average exercise price
$0.200
$0.105
$0.046
$0.15
Key assumptions for fair value calculation, stock options
The fair value calculations are based on the following assumptions:
 
Nine Months Ended
September 30, 2015
Nine Months Ended
September 30, 2014
Risk free interest rate
0.04% − 3.28%
0.04% − 3.73%
Expected life (years)
3.26 – 6.33
2.82 – 7.00
Expected volatility
120.74% – 198.38%
93.63% – 198.38%
Expected dividends
None
None
The fair value calculations are based on the following assumptions:
 
Year Ended
December 31, 2014
Year Ended
December 31, 2013
Risk free interest rate
0.04% - 3.73%
0.40% - 4.92%
Expected life (years)
3.26 - 7.00
2.82 - 7.00
Expected volatility
91.99% - 198.38%
91.99% - 198.38%
Expected dividends
None
None
Estimated average forfeiture rate
10%
10%
Allocation of stock-based compensation expense related to stock option grants

The following table summarizes the allocation of stock-based compensation expense related to stock option grants for the three- and nine-month periods ended September 30, 2015 and 2014.

 
Three Months Ended September 30,
Nine Months Ended September 30,
 
2015
2014
2015
2014
Research and development
$
35
 
$
16
 
$
148
 
$
64
 
Sales and marketing
 
26
 
 
17
 
 
112
 
 
54
 
General and administrative
 
47
 
 
29
 
 
192
 
 
112
 
Director options
 
8
 
 
3
 
 
35
 
 
12
 
Stock-based compensation expense
$
116
 
$
65
 
$
487
 
$
242
 
There were no stock options exercised during the years ended December 31, 2014 and 2013.
 
Year Ended
December 31,
2014
Year Ended
December 31,
2013
Research and development
$
77
 
$
262
 
Sales and marketing
 
72
 
 
100
 
General and administrative
 
134
 
 
410
 
Director options
 
15
 
 
47
 
Stock-based compensation expense included in operating expenses
$
298
 
$
819
 
Summary of option activity

A summary of option activity under the Company’s plans as of September 30, 2015 and 2014 is as follows:

 
2015
2014
Options
Shares
Weighted
Average
Exercise
Price Per
Share
Weighted
Average
Remaining
Contractual
Term (Years)
Aggregate
Intrinsic
Value
Shares
Weighted
Average
Exercise
Price Per
Share
Weighted
Average
Remaining
Contractual
Term (Years)
Aggregate
Intrinsic
Value
Outstanding at January 1,
 
72,012
 
$
0.04
 
 
 
 
$
 
 
69,537
 
$
0.05
 
 
 
 
$
 
Granted
 
36,633
 
$
0.02
 
 
 
 
$
 
 
2,500
 
$
0.03
 
 
 
 
$
 
Forfeited or expired
 
(2,150
)
$
0.03
 
 
 
 
$
 
 
(1,077
)
$
0.05
 
 
 
 
$
 
Outstanding at September 30
 
106,495
 
$
0.04
 
 
4.39
 
$
 
 
70,960
 
$
0.05
 
 
4.30
 
$
 
Vested and expected to vest at September 30
 
103,820
 
$
0.03
 
 
3.21
 
$
 
 
63,996
 
$
0.05
 
 
4.30
 
$
 
Exercisable at September 30
 
69,757
 
$
0.04
 
 
3.53
 
$
 
 
55,102
 
$
0.05
 
 
3.98
 
$
 

The summary activity for the Company’s 2009 and 2011 Stock Compensation Plans, the 1999 Option Plan and Individual Plans is as follows:

 
December 31, 2014
December 31, 2013
 
Shares
Weighted
Average
Exercise
Price
Aggregate
Intrinsic
Value
Weighted
Average
Remaining
Contractual
Life
Shares
Weighted
Average
Exercise
Price
Aggregate
Intrinsic
Value
Weighted
Average
Remaining
Contractual
Life
Outstanding at beginning of period
 
69,537
 
$
0.05
 
 
 
 
 
 
 
 
44,529
 
$
0.05
 
 
 
 
 
 
 
Granted
 
4,500
 
$
0.02
 
$
27
 
 
 
 
 
26,553
 
$
0.04
 
 
 
 
 
 
Forfeited/ Cancelled
 
(2,025
)
$
0.11
 
 
 
 
 
 
 
 
(1,545
)
$
0.11
 
 
 
 
 
 
 
Outstanding at period end
 
72,012
 
$
0.04
 
 
 
 
4.18
 
 
69,537
 
$
0.05
 
 
 
 
5.02
 
Options vested and exercisable at period end
 
57,058
 
$
0.05
 
$
7
 
 
3.86
 
 
43,379
 
$
0.05
 
 
 
 
4.61
 
Weighted average grant-date fair value of options granted during the period
$
0.04
 
 
 
 
 
 
 
 
 
 
$
0.04
 
 
 
 
 
 
 
 
 
 
Summary of the significant ranges of outstanding and exercisable options

The following table summarizes significant ranges of outstanding and exercisable options as of September 30, 2015:

 
Options Outstanding
Options Exercisable
Range of Exercise Prices
Number
Outstanding
Weighted
Average
Remaining
Contractual
Life (in years)
Weighted
Average
Exercise
Price Per
Share
Number
Outstanding
Weighted
Average
Exercise
Price Per
Share
$ 0.01 – $0.02
 
3,000
 
 
6.23
 
$
0.02
 
 
584
 
$
0.02
 
$ 0.02 – $0.03
 
53,170
 
 
5.21
 
$
0.02
 
 
23,107
 
$
0.02
 
$ 0.03 – $0.06
 
31,416
 
 
4.06
 
$
0.05
 
 
27,157
 
$
0.05
 
$ 0.06 – $0.20
 
18,909
 
 
2.32
 
$
0.07
 
 
18,909
 
$
0.07
 
 
 
106,495
 
 
4.39
 
$
0.04
 
 
69,757
 
$
0.04
 

The following table summarizes significant ranges of outstanding and exercisable options as of December 31, 2014:

 
Options Outstanding
Options Exercisable
Range of Exercise Prices
Options
Outstanding
Weighted Average
Remaining Contractual
Life (in years)
Weighted
Average
Exercise Price
Number
Outstanding
Weighted
Average
Exercise Price
$0.00 – $0.50
 
72,012
 
 
4.18
 
$
0.04
 
 
57,058
 
$
0.05
 
Summary of the status of the Company's non-vested shares

The following table summarizes the Company’s non-vested option shares as of September 30, 2015:

Non-vested Option Shares
Shares
Weighted Average
Grant-Date
Fair Value
Non-vested at January 1, 2015
 
14,954
 
$
0.04
 
Granted
 
36,633
 
$
0.02
 
Forfeited
 
(1,020
)
$
0.02
 
Vested
 
(13,829
)
$
0.03
 
Non-vested at September 30, 2015
 
36,738
 
$
0.02
 
 

A summary of the status of the Company’s non-vested shares as of December 31, 2014 is as follows:

Non-vested Shares
Shares
Weighted Average
Grant-Date
Fair Value
Non-vested at January 1, 2013
 
26,158
 
$
0.04
 
Granted
 
4,500
 
$
0.04
 
Forfeited
 
(598
)
$
0.03
 
Vested
 
(15,106
)
$
0.04
 
Non-vested at December 31, 2014
 
14,954
 
$
0.04
 
Information with respect to the classes of Preferred Stock

Information with respect to the class of Preferred Stock at September 30, 2015 is as follows:

Class of Preferred Stock
Annual
Dividend
Annual Dividend Payable,
in Cash or In Kind
Liquidation
Preference
Conversion
Price
Total
Preferred
Shares
Outstanding
Common
Shares to be
issued if
Fully
Converted
Series A-1
 
8
%
Quarterly in Arrears
$
1.00
 
$
0.1400
 
 
929
 
 
6,633
 
Series B
 
10
%
Quarterly in Arrears
$
1.50
 
$
0.0433
 
 
13,191
 
 
304,430
 
Series C
 
10
%
Quarterly in Arrears
$
1.50
 
$
0.0225
 
 
5,356
 
 
238,056
 
Series D-1
 
10
%
Quarterly in Arrears
$
1.00
 
$
0.0225
 
 
7,878
 
 
350,127
 
Series D-2
 
10
%
Quarterly in Arrears
$
1.00
 
$
0.0500
 
 
6,223
 
 
124,470
 

Information with respect to the classes of Preferred Stock at December 31, 2014 is as follows:

Class of
Preferred Stock
Issue Date
Annual
Dividend
Annual
Dividend
Payable, in
Cash or
In Kind
Liquidation
Preference
Conversion
Price
Total
Preferred
Shares
Outstanding
Common
Shares to
be issued if
Fully
Converted
Series A-1
May 2008
 
8
%
Quarterly in Arrears
$
1.00
 
$
0.1400
 
 
875
 
 
6,252
 
Series B
August 2010
 
10
%
Quarterly in Arrears
$
1.50
 
$
0.0433
 
 
12,251
 
 
282,750
 
Series C
December/
March 2011
 
10
%
Quarterly in Arrears
$
1.50
 
$
0.0225
 
 
4,975
 
 
221,104
 
Series D-1
November 2012/
May and
December 2013
 
10
%
Quarterly in Arrears
$
1.00
 
$
0.0225
 
 
5,800
 
 
257,773
 
Series D-2
November 2012/
May and
December 2013
 
10
%
Quarterly in Arrears
$
1.00
 
$
0.0500
 
 
5,720
 
 
114,400
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
882,279
 
Information with respect to dividends issued on the Company's preferred stock

Information with respect to in-kind dividends issued on the Company’s Preferred Stock for the three and nine-month periods ended September 30, 2015 and September 30, 2014 is as follows:

 
Dividends
Beneficial Conversion Feature Related to Dividends
 
Three Months Ended
September 30,
Nine Months Ended
September 30,
Three Months Ended
September 30,
Nine Months Ended
September 30,
 
2015
2014
2015
2014
2015
2014
2015
2014
Series A-1
$
18
 
$
22
 
$
53
 
$
63
 
$
 
$
 
$
 
$
 
Series B
 
324
 
 
294
 
 
939
 
 
852
 
 
 
 
 
 
 
 
 
Series C
 
132
 
 
119
 
 
382
 
 
345
 
 
 
 
64
 
 
13
 
 
114
 
Series D-1
 
192
 
 
128
 
 
516
 
 
329
 
 
 
 
107
 
 
16
 
 
151
 
Series D-2
 
153
 
 
145
 
 
445
 
 
400
 
 
 
 
 
 
 
 
 
Total
$
819
 
$
708
 
$
2,335
 
$
1,989
 
$
 
$
171
 
$
29
 
$
265
 

Information with respect to dividends issued on the Company’s Preferred stock for the years ended December 31, 2014 and 2013 is as follows:

 
December 31,
December 31,
 
2014
2013
2014
2013
 
Dividends
Beneficial Conversion Feature
Related to dividends
Series A-1
$
82
 
$
78
 
$
 
$
 
Series B
 
1,149
 
 
1,044
 
 
 
 
 
Series C
 
468
 
 
433
 
 
152
 
 
191
 
Series D-1
 
472
 
 
131
 
 
195
 
 
59
 
Series D-2
 
541
 
 
402
 
 
 
 
 
Total
$
2,712
 
$
2,088
 
$
347
 
$
250
 
Summary of warrants excercises

A summary of the warrant activity is as follows:

 
September 30, 2015
September 30, 2014
 
Warrants
Weighted
Average
Exercise Price
Per Share
Warrants
Weighted
Average
Exercise Price
Per Share
Outstanding at beginning of period
 
213,521
 
$
0.0284
 
 
77,155
 
$
0.0289
 
Issued
 
40,560
 
 
0.0193
 
 
124,711
 
 
0.0275
 
Expired/Cancelled
 
(16,259
)
 
0.0500
 
 
(28,052
)
 
0.0225
 
Outstanding at end of period
 
237,822
 
$
0.0264
 
 
173,814
 
$
0.0286
 
Exercisable at end of period
 
237,822
 
$
0.0264
 
 
173,814
 
$
0.0286
 

Summary of Warrant exercises in 2014 and 2013:

 
December 31,2014
December 31, 2013
 
Warrants
Common
Shares
Issued
Cash
received
Warrants
Common
Shares
Issued
Cash
received
 
 
 
 
 
$
 
 
1,300
 
 
1,300
 
$
29
 
 
 
 
 
 
$
 
 
11,111
 
 
2,283
 
$
 
Total
 
 
 
 
$
 
 
12,411
 
 
3,583
 
$
29
 
Summary of warrants issued to related party and other  

Summary of warrants issued in 2014 and 2013:

 
December 31, 2014
December 31, 2013
 
Related
Party
Other
Total
Related
Party
Other
Total
Warrants issued in connection with Notes
 
 
 
 
 
 
 
19,584
 
 
2,083
 
 
21,667
 
Warrants issued with purchase of Series D Preferred
 
6,159
 
 
15,259
 
 
21,418
 
 
9,561
 
 
9,428
 
 
18,989
 
Warrants issued in the December Series D Preferred exchange
 
 
 
 
 
 
 
 
 
 
2,827
 
 
7,627
 
 
10,454
 
Warrants issued with line of credit
 
 
 
11,564
 
 
11,564
 
 
 
 
 
 
 
Contingent Warrants issued
 
34,062
 
 
86,723
 
 
120,785
 
 
 
 
 
 
 
Total
 
40,221
 
 
113,546
 
 
153,767
 
 
31,972
 
 
19,138
 
 
51,110
 
Summary of the warrants issued

A summary of the warrant activity is as follows:

 
September 30, 2015
September 30, 2014
 
Warrants
Weighted
Average
Exercise Price
Per Share
Warrants
Weighted
Average
Exercise Price
Per Share
Outstanding at beginning of period
 
213,521
 
$
0.0284
 
 
77,155
 
$
0.0289
 
Issued
 
40,560
 
 
0.0193
 
 
124,711
 
 
0.0275
 
Expired/Cancelled
 
(16,259
)
 
0.0500
 
 
(28,052
)
 
0.0225
 
Outstanding at end of period
 
237,822
 
$
0.0264
 
 
173,814
 
$
0.0286
 
Exercisable at end of period
 
237,822
 
$
0.0264
 
 
173,814
 
$
0.0286
 

A summary of the outstanding warrants is as follows:

 
December 31, 2014
December 31, 2013
 
Warrants
Weighted Average
Exercise Price
Warrants
Weighted Average
Exercise Price
Outstanding at beginning of period
 
77,155
 
$
0.0289
 
 
151,722
 
$
0.0269
 
Issued
 
153,767
 
$
0.0275
 
 
51,110
 
$
0.0283
 
Exercised
 
 
 
 
 
(12,411
)
$
0.0225
 
Expired
 
(17,401
)
$
0.0225
 
 
(113,266
)
$
0.0230
 
Outstanding at end of period
 
213,521
 
$
0.0284
 
 
77,155
 
$
0.0289
 
Exercisable at end of period
 
213,521
 
$
0.0284
 
 
77,155
 
$
0.0289
 
Status of the warrants outstanding

A summary of the status of the warrants outstanding and exercisable as of September 30, 2015 is as follows:

Number of Warrants
Weighted Average Remaining Life (Years)
Weighted Average Exercise Price Per Share
Warrants
 
27,400
 
 
2.52
 
$
0.0225
 
Warrants
 
193,968
 
 
1.26
 
$
0.0275
 
Warrants
 
3,294
 
 
0.13
 
$
0.0500
 
Warrants
 
13,160
 
 
2.83
 
$
0.0125
 
 
 
237,822
 
 
1.48
 
$
0.0264
 

A summary of the status of the warrants outstanding as of December 31, 2014 is as follows:

Number of Warrants
Outstanding and Exercisable
Weighted Average
Remaining Life
Weighted Average
Exercise Price per share
8,643
 
1.95
 
$
0.0275
 
204,878
 
0.52
 
$
0.0500
 
213,521
 
1.89
 
$
0.0284